Technavio market research analysts foresee positive growth for many segments of the infectious and rare diseases industry in the next five years. In their recent market analysis, Technavio talks about three booming segments, under the automotive industry that are anticipated to generate considerable revenues and grow at a consistent rate during the forecast period.
Purchase these reports and get USD 1200 worth of free additional custom research information on any report.
Global Antifungal Drugs Market 2017-2021
The global antifungal drugs market is anticipated to experience substantial growth during the forecast period, fueled by factors such as unhygienic living conditions, increased awareness about fungal infections, and the rise in the prevalence of fungal infections.
According to the research analysts at Technavio, the global market for antifungal drugs is projected to undergo several pharmaceutical R&D activities. The market is also anticipated to benefit from health insurance transformations at both, international and regional levels. Allergan, Merck, Allergy Therapeutics, Novatics, GSK, Shire, and Sandoz are some of the leading infectious and rare diseases drug manufacturing companies. Request a sample report.
Global Atopic Dermatitis Drugs Market 2017-2021
The report covers the present scenario and the growth prospects of the global atopic dermatitis drugs market over the next five years.
The growth of the global market for atopic dermatitis drugs is expected to be fueled by the increased focus given to dermatology diagnostic devices and drugs in their product portfolios by pharmaceutical companies. Their key areas of focus include premium drug prices, tax grants, extended market exclusivities, high unmet need, and reduced timeframes for clinical development. Increased preference for pharmacological products in the developing countries owing to growing exposure, disposable income, and improving healthcare infrastructure is also expected to be an incentive for the growth of the market during the forecast period. Request a sample report.
Global Alopecia Drugs Market 2016-2020
Technavio analysts forecast the global alopecia drugs to experience steady growth during the forecast period 2017-2021.
Technavio researchers predict the global market for alopecia drugs to register growth at a CAGR of more than 5%, fueled by the high uptake of approved therapies. High unmet needs coupled with the success of existing approved drugs is prompting vendors in the market to focus on the development of new treatment therapies. GlaxoSmithKline, Johnson & Johnson, and Merck are the leading alopecia drugs manufacturers in the global market. Request a sample report.
Become a Technavio member and get unlimited access to 6000+ reports from across a vast range of industries, including 300+ reports on infectious and rare diseases. We can also modify a subscription plan according to individual preferences or enterprise requirements and make it pocket-friendly.
Browse related reports:
- Global Hypertension Drugs Market 2016-2020
- COPD Drugs Market in China 2016-2020
- Global MRSA Drugs Market 2016-2020
To read more press releases – click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
